| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1192.62 | 96 |
| GSM780708 | Untreated after 4 days (C2_1) | 1179.89 | 96 |
| GSM780709 | Untreated after 4 days (C3_1) | 1037.09 | 96 |
| GSM780719 | Untreated after 4 days (C1_2) | 1323.7 | 97 |
| GSM780720 | Untreated after 4 days (C2_2) | 1136.05 | 96 |
| GSM780721 | Untreated after 4 days (C3_2) | 1101 | 96 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1199.87 | 96 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1178.79 | 96 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1374.96 | 97 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1280.92 | 97 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1025.24 | 96 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1231.49 | 96 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1226.08 | 96 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1267.2 | 96 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1138.93 | 96 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1249.51 | 96 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1257.69 | 96 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1209.56 | 96 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1016.88 | 96 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1425.47 | 97 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1213.84 | 96 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1374.96 | 97 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1125.65 | 96 |